Literature DB >> 25466956

Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Nasser Ebrahimi Daryani1, Maryam Sadr, Shirin Moossavi, Sepideh Shahkarami, Samaneh Soltani, Elham Farhadi, Nima Rezaei.   

Abstract

BACKGROUND AND AIM: Interleukin (IL)-1 family members play an important role in the pathogenesis of inflammatory bowel disease (IBD). There are conflicting results regarding the association of IL-1 gene cluster single nucleotide polymorphisms (SNPs) with IBD and its clinical features. The aim of this study was to examine IL-1α -889 C/T, IL-1β -511 C/T, IL-1β +3962 C/T, IL-1R Pst-I1970 C/T, and IL-1RA Mspa-I11100 C/T SNPs in Iranian patients.
METHODS: In this study, SNPs of IL-1 family members were investigated in 75 patients with IBD (40 CD and 35 UC), using polymerase chain reaction with sequence-specific primers method.
RESULTS: IL-1β -511 CC genotype was significantly less present in UC compared to controls, while IL-1RA Mspa-I11100 CC was significantly associated with both Crohn's disease (CD) and ulcerative colitis (UC). IL-1α -889 TT genotype was more frequently associated with extraintestinal manifestations. A significant association was observed between IL-1β +3962 TT genotype and the disease activity in IBD. IL-1RA Mspa-I11100 CC was significantly less frequent in CD patients who need immunosuppressive therapy. IL-1RA Mspa-I11100 CT was associated with earlier age of onset in IBD, while TT genotype was associated with higher age of onset in IBD.
CONCLUSIONS: IL-1 SNPs seem to be associated with IBD and could affect the disease severity as well.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25466956     DOI: 10.1007/s10620-014-3457-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  56 in total

1.  Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease.

Authors:  A Nemetz; A Köpe; T Molnár; A Kovács; J Fehér; Z Tulassay; F Nagy; M A García-González; A S Peña
Journal:  Scand J Gastroenterol       Date:  1999-02       Impact factor: 2.423

2.  Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.

Authors:  Yasemin Celik; Ulkü Dagli; Mesut Yalin Kiliç; Murat Törüner; Senem Ceren Ozen; Muhip Ozkan; Irfan Soykan; Hülya Cetinkaya; Aysel Ulker; Ali Ozden; A Mithat Bozdayi
Journal:  Scand J Gastroenterol       Date:  2006-05       Impact factor: 2.423

3.  IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Authors:  Moshe Elkabets; Vera S G Ribeiro; Charles A Dinarello; Suzanne Ostrand-Rosenberg; James P Di Santo; Ron N Apte; Christian A J Vosshenrich
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

4.  Cytokine single nucleotide polymorphisms in Iranian populations.

Authors:  Ali Akbar Amirzargar; Mehrnaz Naroueynejad; Farideh Khosravi; Seyed Saied Dianat; Saied Dianat; Nima Rezaei; Joannis Mytilineos; Behrouz Nikbin
Journal:  Eur Cytokine Netw       Date:  2008-06-01       Impact factor: 2.737

5.  Cytokine gene polymorphisms in inflammatory bowel disease.

Authors:  E Louis; J Satsangi; M Roussomoustakaki; M Parkes; G Fanning; K Welsh; D Jewell
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

6.  Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.

Authors:  M J Carter; F S di Giovine; S Jones; J Mee; N J Camp; A J Lobo; G W Duff
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Proinflammatory cytokine gene polymorphisms in Behçet's disease.

Authors:  Aliakbar Amirzargar; Farhad Shahram; Enayat Nikoopour; Nima Rezaei; Keyvan Saeedfar; Naghmeh Ziaei; Fereydoun Davatchi
Journal:  Eur Cytokine Netw       Date:  2010-11-09       Impact factor: 2.737

8.  Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia.

Authors:  A A Amirzargar; M Bagheri; A Ghavamzadeh; K Alimoghadam; F Khosravi; N Rezaei; M Moheydin; B Ansaripour; B Moradi; B Nikbin
Journal:  Int J Immunogenet       Date:  2005-06       Impact factor: 1.466

9.  Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression.

Authors:  R Kimura; T Nishioka; A Soemantri; T Ishida
Journal:  Genes Immun       Date:  2004-11       Impact factor: 2.676

10.  Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).

Authors:  S Dionne; I D D'Agata; J Hiscott; T Vanounou; E G Seidman
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

View more
  4 in total

1.  Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome?

Authors:  Manuel Muro; Anna Mrowiec
Journal:  Dig Dis Sci       Date:  2015-05       Impact factor: 3.199

2.  Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis.

Authors:  Maria Dobre; Elena Milanesi; Teodora Ecaterina Mănuc; Dorel Eugen Arsene; Cristian George Ţieranu; Carlo Maj; Gabriel Becheanu; Mircea Mănuc
Journal:  J Immunol Res       Date:  2018-10-17       Impact factor: 4.818

3.  A functional genomics predictive network model identifies regulators of inflammatory bowel disease.

Authors:  Lauren A Peters; Jacqueline Perrigoue; Arthur Mortha; Alina Iuga; Won-Min Song; Eric M Neiman; Sean R Llewellyn; Antonio Di Narzo; Brian A Kidd; Shannon E Telesco; Yongzhong Zhao; Aleksandar Stojmirovic; Jocelyn Sendecki; Khader Shameer; Riccardo Miotto; Bojan Losic; Hardik Shah; Eunjee Lee; Minghui Wang; Jeremiah J Faith; Andrew Kasarskis; Carrie Brodmerkel; Mark Curran; Anuk Das; Joshua R Friedman; Yoshinori Fukui; Mary Beth Humphrey; Brian M Iritani; Nicholas Sibinga; Teresa K Tarrant; Carmen Argmann; Ke Hao; Panos Roussos; Jun Zhu; Bin Zhang; Radu Dobrin; Lloyd F Mayer; Eric E Schadt
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

4.  Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis.

Authors:  Fang Cheng; Qiang Li; Jinglin Wang; Fang Zeng; Kaiping Wang; Yu Zhang
Journal:  Dis Markers       Date:  2020-10-21       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.